12:00 AM
 | 
Oct 18, 1999
 |  BC Week In Review  |  Company News  |  Deals

LeukoSite, Millennium deal

MLNM will acquire LKST for $635 million in stock (see BioCentury Extra, Oct. 15). LKST shareholders will...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >